Aerovate Therapeutics (AVTE) Q2 2024 Earnings

May 13Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.83
-0.55
-0.28
0

Details

Expected EPS
-0.764567
Actual EPS
-0.83
Surprise EPS
-0.07
Surprise Percent
-8.56%

Description

⁨Aerovate Therapeutics⁩ (⁦AVTE⁩) has reported earnings of ⁦-0.83⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts